PRADO
PRADO is a global, independent leader in providing preclinical services including toxicity testing, development of animal models, pharmacokinetic studies, biocompatibility, pathology services, and specialized research in biopharma, biotech, stem cell therapy, and vaccine development. Based in Pune, India, PRADO supports industries such as pharmaceutical, biopharma, biotech, medical devices, agrochemicals, food, vaccines, and animal health by delivering high-quality, regulatory-compliant preclinical data to facilitate product registration and approval. The organization emphasizes quality, timeliness, integrity, and flexibility, aiming to be a trusted partner in the regulatory journey of new product development.
Industries
Nr. of Employees
small (1-50)
PRADO
Mawal, Maharashtra, India
Products
Pharmacokinetics Services
Preclinical pharmacokinetic study services designed to help healthcare innovations reach the market faster and safer.
Preclinical Toxicology Testing Services
Comprehensive preclinical toxicology testing services delivered by GLP-certified facilities to support pharmaceuticals, biopharma, biotech, and medical devices.
Medical Device Biocompatibility Testing
Biocompatibility and risk assessment testing services for medical devices to ensure safety and regulatory compliance.
Animal Research Facility (ARF)
Designed to meet international standards for small laboratory animal studies, our ARF is CPCSEA-approved and ensures ethical, well-regulated research.
Pathology Services
Comprehensive evaluation and interpretation of biological samples to support toxicology, pharmacology, and clinical studies, including necropsy, histopathology, immunohistochemistry, and clinical pathology.
Animal Model Development Services
Animal disease model services supporting research organizations with ethical animal studies conducted in a CPCSEA-approved facility.
Pharmacokinetics Services
Preclinical pharmacokinetic study services designed to help healthcare innovations reach the market faster and safer.
Preclinical Toxicology Testing Services
Comprehensive preclinical toxicology testing services delivered by GLP-certified facilities to support pharmaceuticals, biopharma, biotech, and medical devices.
Medical Device Biocompatibility Testing
Biocompatibility and risk assessment testing services for medical devices to ensure safety and regulatory compliance.
Animal Research Facility (ARF)
Designed to meet international standards for small laboratory animal studies, our ARF is CPCSEA-approved and ensures ethical, well-regulated research.
Pathology Services
Comprehensive evaluation and interpretation of biological samples to support toxicology, pharmacology, and clinical studies, including necropsy, histopathology, immunohistochemistry, and clinical pathology.
Animal Model Development Services
Animal disease model services supporting research organizations with ethical animal studies conducted in a CPCSEA-approved facility.
Services
Regulatory and discovery toxicology studies (acute, subacute, sub-chronic, chronic, developmental/reproductive, inhalation) conducted under GLP.
Clinical pathology, necropsy, histopathology slide preparation and evaluation, special staining and immunohistochemistry for integration with toxicology and efficacy studies.
PK and tissue distribution studies with single, multiple and cassette dosing across multiple species and administration routes to support ADME and safety assessments.
Comprehensive genotoxicity and in vitro testing services including Ames, micronucleus, chromosomal aberration and gene mutation assays with bioanalytical support.
Development and standardization of in vivo and in vitro disease models (inflammation, pain, metabolic disorders, antipsychotic/neurobehavioral models, osteoporosis, wound healing, glaucoma and custom models) for efficacy and mechanism studies.
Device biocompatibility evaluations including cytotoxicity, hemocompatibility, implantation, sensitization, irritation and systemic toxicity testing to support device safety submissions.
Regulatory and discovery toxicology studies (acute, subacute, sub-chronic, chronic, developmental/reproductive, inhalation) conducted under GLP.
Clinical pathology, necropsy, histopathology slide preparation and evaluation, special staining and immunohistochemistry for integration with toxicology and efficacy studies.
PK and tissue distribution studies with single, multiple and cassette dosing across multiple species and administration routes to support ADME and safety assessments.
Comprehensive genotoxicity and in vitro testing services including Ames, micronucleus, chromosomal aberration and gene mutation assays with bioanalytical support.
Development and standardization of in vivo and in vitro disease models (inflammation, pain, metabolic disorders, antipsychotic/neurobehavioral models, osteoporosis, wound healing, glaucoma and custom models) for efficacy and mechanism studies.
Device biocompatibility evaluations including cytotoxicity, hemocompatibility, implantation, sensitization, irritation and systemic toxicity testing to support device safety submissions.
Expertise Areas
- Preclinical toxicology
- Genotoxicity testing
- Pharmacokinetics and tissue distribution
- Pathology and histopathology
Key Technologies
- Good Laboratory Practice (GLP) systems
- Biosafety level 2 tissue culture facilities
- ELISA and antibody detection assays
- Neutralization assays
News & Updates
Recognition for Dr. Wangikar's expertise in toxicology, enhancing PRADO's credibility.
Recognition for Dr. Wangikar's expertise in toxicology, enhancing PRADO's credibility.